REQUEST A DEMO
Total
USD $0.00
Search more companies

Synmosa Biopharma Corporation (Taiwan, China)

Main Activities: Chemical Manufacturing
Full name: Synmosa Biopharma Corporation Profile Updated: May 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Jianjiao Cell Medicine Biotech Co., Ltd. (SYNMOSABIOPHARMACOPORATION), was established in August 1970, formerly known as the "cell chemical and pharmaceutical". It started with distributing Orion series products. It was engaged in western ingot production, capsules, ointments and other products. In April 2001,it combined with the Pedro trade and restructured to establish "Jianqiao Cell Pharmaceutical Biotech" . In May 2003 it went listed. The main products include tablets, the film-coated tablets, liquid, capsule and other products. The therapeutic class mainly covers high blood pressure, cardiovascular, menopausal, asthma, allergies, rhinitis, and musculoskeletal medicine.

Headquarters
11Th Fl., No.396, Sec. 1, Neihu Road
Taipei City; Taipei City;

Contact Details: Purchase the Synmosa Biopharma Corporation report to view the information.

Website: http://www.synmosa.com.tw

Basic Information
Total Employees:
Purchase the Synmosa Biopharma Corporation report to view the information.
Outstanding Shares:
Purchase the Synmosa Biopharma Corporation report to view the information.
Financial Auditors:
Purchase the Synmosa Biopharma Corporation report to view the information.
Incorporation Date:
August 25, 1970
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
6.41%
Purchase this report to view the information.
3.48%
Purchase this report to view the information.
0.35%
Purchase this report to view the information.
0.29%
Purchase this report to view the information.
Subsidiaries
Synmosa Biopharma Pte.Ltd (Singapore)
100%
亞吉費國際有限公司 (Samoa)
100%
健康化學製藥股份有限公司
100%
Company Performance
Financial values in the chart are available after Synmosa Biopharma Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
1.77%
Total operating revenue
1.81%
Operating profit (EBIT)
26.54%
EBITDA
3.59%
Net Profit (Loss) for the Period
42.63%
Total assets
-3.87%
Total equity
8%
Operating Profit Margin (ROS)
2.96%
Net Profit Margin
3.16%
Return on Equity (ROE)
0.85%
Debt to Equity Ratio
-3.9%
Quick Ratio
0.11%
Cash Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?